Evidence map›Paper›PMID 39595522›Full record

ReviewBiomolecules2024

The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases.

Majid Eslami, Farnaz Alibabaei, Ali Babaeizad, Seyedeh Zahra Banihashemian, Mahdi Mazandarani, Aref Hoseini, Mohammad Ramezankhah, Valentyn Oksenych, Bahman Yousefi

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Majid EslamiDepartment of Bacteriology and Virology, Semnan University of Medical Sciences, Semnan 35134, Iran.ORCID 0000-0001-5118-678X
Farnaz AlibabaeiStudent Research Committee, School of Medicine, Semnan University of Medical Sciences, Semnan 35134, Iran.
Ali BabaeizadSchool of Medicine, Semnan University of Medical Sciences, Semnan 35134, Iran.
Seyedeh Zahra BanihashemianSchool of Medicine, Semnan University of Medical Sciences, Semnan 35134, Iran.ORCID 0000-0003-2231-1726
Mahdi MazandaraniEndocrinology and Metabolism Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran 11369, Iran.ORCID 0000-0001-8972-6171
Aref HoseiniStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari 49414, Iran.ORCID 0000-0002-2110-0321
Mohammad RamezankhahStudent Research Committee, Faculty of Medicine, Babol University of Medical Sciences, Babol 47134, Iran.
Valentyn OksenychDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0002-5088-3791
Bahman YousefiCancer Research Center, Faculty of Medicine, Semnan University of Medical Sciences, Semnan 35134, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota is a complex ecosystem that influences digestion, immune response, metabolism, and has been linked to health and well-being. Choline is essential for neurotransmitters, lipid transport, cell-membrane signaling, methyl-group metabolism and is believed to have neuroprotective properties. It is found in two forms, water-soluble and lipid-soluble, and its metabolism is different. Long-term choline deficiency is associated with many diseases, and supplements are prescribed for improved health. Choline supplements can improve cognitive function in adults but not significantly. Choline is a precursor of phospholipids and an acetylcholine neurotransmitter precursor and can be generated de novo from phosphatidylcholine via phosphatidylethanolamine-N-methyltransferase and choline oxidase. Choline supplementation has been found to have a beneficial effect on patients with neurodegenerative diseases, such as Alzheimer's disease (AD), by increasing amyloid-β, thioflavin S, and tau hyper-phosphorylation. Choline supplementation has been shown to reduce amyloid-plaque load and develop spatial memory in an APP/PS1 mice model of AD. Choline is necessary for normative and improved function of brain pathways and can reduce amyloid-β deposition and microgliosis. Clinical research suggests that early neurodegenerative diseases (NDs) can benefit from a combination of choline supplements and the drugs currently used to treat NDs in order to improve memory performance and synaptic functioning.

Indexed as

CholineGastrointestinal MicrobiomeNeurodegenerative DiseasesAlzheimer DiseaseAnimalsDietary SupplementsHumansCholinecholinemetabolismmicrobiotaneurodegenerative diseasesTMAO

Identifiers

PMID39595522
PMCPMC11591558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.